HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mucocutaneous leishmaniasis in a patient treated with anti-TNF-α therapy.

AuthorsEstrella Garcia-Gonzalez, Giacomo M Guidelli, Marco Bardelli, Roberta Maggio
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 51 Issue 8 Pg. 1517-8 (Aug 2012) ISSN: 1462-0332 [Electronic] England
PMID22427411 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Adalimumab
  • Methylprednisolone
  • Methotrexate
Topics
  • Adalimumab
  • Antibodies, Monoclonal, Humanized (administration & dosage, adverse effects)
  • Antirheumatic Agents (administration & dosage, adverse effects)
  • Biopsy
  • Blotting, Western
  • Drug Therapy, Combination
  • Enzyme-Linked Immunosorbent Assay
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Leishmania infantum (isolation & purification)
  • Leishmaniasis, Mucocutaneous (diagnosis, etiology, pathology)
  • Male
  • Methotrexate (administration & dosage)
  • Methylprednisolone (administration & dosage)
  • Middle Aged
  • Opportunistic Infections (diagnosis, etiology, pathology)
  • Spondylitis, Ankylosing (drug therapy)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: